Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Acute Myeloid Leukemia Research

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on the diagnosis, management, and genomic classification of Acute Myeloid Leukemia (AML). It covers topics such as prognostic factors, clonal hematopoiesis, FLT3 mutations, epigenetic landscapes, therapeutic trials, and the role of hematopoietic stem cells in AML.

274
Works

How has Acute Myeloid Leukemia Research's publication output changed over time?

ScholarIQpublication output · 1999–2022

Output grew0% over the shown period — from 1 works in 1999 to 1 in 2022.

1
1
1
1
1
1
2
1
2
1
1999200220112014201520162017201820202022

What are the most-cited papers on Acute Myeloid Leukemia Research?

ScholarIQmost cited works
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese, Anna K. Kähler, Robert E. Handsaker, Johan Lindberg, Samuel A. Rose, Samuel F. Bakhoum, Kimberly Chambert, Eran Mick, Benjamin M. Neale, Menachem Fromer, Shaun Purcell, Oscar Svantesson, Mikael Landén, Martin Höglund, Sören Lehmann, Stacey B. Gabriel, Jennifer L. Moran, Eric S. Lander, Patrick F. Sullivan, Pamela Sklar, Henrik Grönberg, Christina M. Hultman, Steven A. McCarroll
New England Journal of Medicine. 20143,528 CitationsOPEN ACCESS
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis
Christian Thiede, Christine Steudel, Brigitte Mohr, Markus Schaich, Ulrike Schäkel, Uwe Platzbecker, Martin Wermke, Martin Bornhäuser, Markus Ritter, Andreas Neubauer, Gerhard Ehninger, Thomas Illmer
Blood. 20021,733 CitationsOPEN ACCESS
Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia
Robert J. Mayer, Roger B. Davis, Charles A. Schiffer, Deborah Berg, Bayard L. Powell, Philip Schulman, George Omura, Joseph O. Moore, O. Ross McIntyre, E Frei
New England Journal of Medicine. 19941,433 CitationsOPEN ACCESS
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
Elli Papaemmanuil, Mario Cazzola, Jacqueline Boultwood, Luca Malcovati, Paresh Vyas, David Bowen, Andrea Pellagatti, James S. Wainscoat, Eva Hellström‐Lindberg, Carlo Gambacorti‐Passerini, Anna L. Godfrey, Inmaculada Rapado, Ana Cvejic, Richard Rance, Chris McGee, Peter Ellis, Laura Mudie, Philip J. Stephens, Stuart McLaren, Charles Massie, Patrick Tarpey, Ignacio Varela, Serena Nik‐Zainal, Helen Davies, Adam Shlien, David Jones, Keiran Raine, Jonathan Hinton, Adam P. Butler, Jon W. Teague, E. Joanna Baxter, J Score, Anna Gallì, Matteo Giovanni Della Porta, Erica Travaglino, Michael J. Groves, Sudhir Tauro, Nikhil C. Munshi, Kristina Anderson, Adel K. El‐Naggar, Andrej Fischer, Ville Mustonen, Alan J. Warren, Nicholas C.P. Cross, Anthony R. Green, P. Andrew Futreal, Michael R. Stratton, Peter J. Campbell
New England Journal of Medicine. 20111,225 CitationsOPEN ACCESS
Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis.
Qing Wang, Terryl Stacy, Michael Binder, M. Marin-Padilla, Arlene H. Sharpe, Nancy A. Speck
Proceedings of the National Academy of Sciences. 19961,186 CitationsOPEN ACCESS

Where is Acute Myeloid Leukemia Research research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock

How much of the research on Acute Myeloid Leukemia Research is open access?

ScholarIQopen access share
87%OPEN ACCESS
Gold
0%
Green
27%
Hybrid
0%
Bronze
60%
Closed
13%

Related on ScholarIQ

Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Paper
Frequent pathway mutations of splicing machinery in myelodysplasia
Paper
A History of Cancer Chemotherapy
Paper
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis
Paper
2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline
Paper
Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients
Paper
470M+ articles · free account